Smith & Nephew is trading at £1207.50 (+4.66%) amid a broad risk-on market tone rather than a clear company-specific event.
- U.S. equity markets are trending higher, with the S&P 500 up 0.79%, the Nasdaq up 0.93%, and the Dow up 1.23%, supporting UK-listed defensives.
- No major company announcements, earnings updates, or analyst actions were identified in available sources to explain the specific price action.
- The move appears consistent with a firmer global market backdrop and positive sentiment across the healthcare sector.